Which account would you like to be logged in as?

Forgot Password?

Sign Up!

Visa/MasterCard and Discover Users
Flip your credit card over and look at the signature box. You should see either the entire 16-digit credit card number or just the last four digits followed by a special 3-digit code. The 3-digit code is your Card Security Code.

American Express Credit Card Users
Look for the 4-digit code printed on the front of your card just above and to the right of your main credit card number. The 4-digit code is your card Identification Number (CID).

What is a discount code?
Generic discount code text needs to go here

Newsletter
jul 25
2011
Release date

Advances in the Management of Non-Hodgkin Lymphoma: Highlights from the 11th International Conference on Malignant Lymphoma

Non-Hodgkin Lymphoma

MEDIA: Newsletter

Estimated time to complete activity: 1.0 hour | Release date: Monday, July 25, 2011 | Expiration date: Tuesday, July 24, 2012

INTRODUCTION

The 11th International Conference on Malignant Lymphoma (ICML) took place June 15-18, 2011, in Lugano, Switzerland. This newsletter provides a comprehensive review of key experimental and clinical data presented at the conference with highlights in scientific advancement, knowledge, and insight gained from this international scientific symposium.

FEATURED CONTENT

Follicular Lymphoma
Mantle Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Treatment Strategies for Elderly Patients
T-Cell Lymphoma
Novel Agents

FACULTY


Bruce D. Cheson, MD

Professor of Medicine
Deputy Chief
Division of Hematology-Oncology
Head of Hematology
Georgetown University Hospital
Lombardi Comprehensive Cancer Center
Washington, District of Columbia

Andrew M. Evens, DO, MSc

Professor of Medicine
Chief, Division of Hematology/Oncology
Tufts University School of Medicine
Director, Lymphoma Program
Leader, Clinical Sciences Program
Tufts Cancer Center
Boston, Massachusetts

TARGET AUDIENCE

The intended audience for this initiative includes medical oncologists, hematologists, hematologist-oncologists, and pathologists charged with the care of the patient with lymphoma.

EDUCATIONAL OBJECTIVES

At the conclusion of this activity, participants should be able to:

  • Describe the potential role of novel treatment approaches in the management of non-Hodgkin lymphoma
  • Discuss the clinical implications of the results of pivotal clinical trials, including early phase trials, that have potential to impact the use of novel therapies in non-Hodgkin lymphoma management
  • Discuss ongoing clinical trials and future directions in non-Hodgkin lymphoma

PHYSICIAN CONTINUING EDUCATION

Accreditation Statement
Educational Concepts Group, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Educational Concepts Group, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHARMACIST CONTINUING EDUCATION

ACPE Logo Educational Concepts Group, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Educational Concepts Group, LLC designates this continuing education activity for 1.0 contact hour (0.10 CEU) (UAN 0199-0000-11-034-H01-P).

Type of activity: Knowledge-based

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME/CE credit for this activity. During the period Monday, July 25, 2011 through Tuesday, July 24, 2012, participants must 1) read the educational objectives and faculty disclosures; 2) study the educational activity; 3) complete the post-activity assessment.

CME/CE CREDIT

Physicians and pharmacists who complete the post-activity assessment with a score of 70% or better may view and print their credit letter or statement of credit via the website, www.educationalconcepts.net.

POLICY ON DISCLOSURE

It is the policy of ECG that the faculty, authors, planners, and other persons who may influence content of this CME/CE activity disclose all relevant financial relationships with commercial interests in order to allow ECG to identify and resolve any potential conflicts of interest.

The Following Faculty Members Have Declared Relevant Financial Relationships

Bruce D. Cheson, MD Consultant Fees Allos Therapeutics, Inc.
Celgene Corporation
Cephalon, Inc.
Gilead Sciences, Inc.
Pharmacyclics, Inc.
Andrew M. Evens, DO, MSc Grants/Research Support Lilly USA, LLC
Millennium Pharmaceuticals, Inc.
Pharmacyclics, Inc.
Seattle Genetics, Inc.
Advisory Boards Celgene Corporation
Millennium Pharmaceuticals, Inc.

Staff Disclosure
Planners and managers at ECG have no relevant financial relationships to disclose.

ACKNOWLEDGEMENT

The editors with to thank Java Solis, MS, for assistance in writing this document.

DISCLOSURE OF OFF-LABEL USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ECG does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity do not necessarily represent the views of ECG. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Please refer to the official prescribing information for each product or consult the Physicians’ Desk Reference for discussion of approved indications, contraindications, and warnings.

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT

This activity is supported by educational grants from the following: Lilly USA, LLC, Merck & Co., Inc.

CME/CE INQUIRIES

For further information, please contact:
Educational Concepts Group, LLC
1300 Parkwood Circle SE, Suite 325
Atlanta, Georgia 30339
Phone: 1.866.933.1681
Fax: 1.866.933.1692
www.educationalconcepts.net

None of the contents may be reproduced in any form without prior written permission from the publisher. This activity may be accessed at www.educationalconcepts.net.

Yes, I have read the information above and am interested in participating.

More Online Activities